Clarivate (CLVT) Expected to Post Quarterly Earnings on Wednesday

Clarivate (NYSE:CLVT) is projected to post its Q2 2026 results before the market opens on Wednesday, July 29th. Analysts expect the company to announce earnings of $0.17 per share and revenue of $589.7290 million for the quarter. Clarivate has set its FY 2026 guidance at 0.700-0.800 EPS. Investors may review the information on the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Wednesday, July 29, 2026 at 9:30 AM ET.

Clarivate (NYSE:CLVT) last issued its quarterly earnings results on Wednesday, April 29th. The company reported $0.18 earnings per share for the quarter, topping the consensus estimate of $0.14 by $0.04. Clarivate had a positive return on equity of 8.82% and a negative net margin of 5.61%.The business had revenue of $585.50 million during the quarter, compared to the consensus estimate of $569.50 million. During the same quarter last year, the company earned $0.14 earnings per share. The company’s quarterly revenue was down 1.4% on a year-over-year basis. On average, analysts expect Clarivate to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Clarivate Price Performance

Shares of CLVT stock opened at $2.25 on Wednesday. Clarivate has a fifty-two week low of $1.66 and a fifty-two week high of $4.77. The company has a debt-to-equity ratio of 0.89, a quick ratio of 0.84 and a current ratio of 0.84. The firm has a market capitalization of $1.44 billion, a price-to-earnings ratio of -10.74 and a beta of 1.38. The stock’s 50-day simple moving average is $2.33 and its 200-day simple moving average is $2.48.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of CLVT. PharVision Advisers LLC acquired a new stake in shares of Clarivate during the third quarter worth about $45,000. Pitcairn Co. purchased a new stake in Clarivate in the second quarter valued at approximately $52,000. Jump Financial LLC purchased a new stake in Clarivate in the fourth quarter valued at approximately $41,000. Tower Research Capital LLC TRC increased its holdings in Clarivate by 165.6% in the 2nd quarter. Tower Research Capital LLC TRC now owns 17,383 shares of the company’s stock worth $75,000 after buying an additional 10,839 shares during the period. Finally, RPO LLC acquired a new position in Clarivate in the 4th quarter worth approximately $64,000. 85.72% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms have weighed in on CLVT. Weiss Ratings reissued a “sell (e+)” rating on shares of Clarivate in a research report on Wednesday, June 24th. Wall Street Zen raised shares of Clarivate from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Finally, Barclays lifted their price objective on shares of Clarivate from $2.40 to $2.50 and gave the stock an “underweight” rating in a research note on Tuesday, July 7th. Four research analysts have rated the stock with a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, Clarivate presently has an average rating of “Reduce” and a consensus target price of $2.98.

About Clarivate

Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.

Originally part of Thomson Reuters’ Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction.